您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版)

• 论文 • 上一篇    下一篇

急性心肌梗死急诊介入治疗中替罗非班对冠状动脉内皮细胞功能的影响

李媛媛,来庆友,商德亚,刘东兴   

  1. 山东大学附属省立医院急诊科, 济南 250021
  • 收稿日期:2007-11-05 修回日期:1900-01-01 出版日期:2008-05-16 发布日期:2008-05-16
  • 通讯作者: 来庆友

Effects of Tirofiban on endothelial function in patients with acute myocardial infarction treated by primary percutaneous coronary intervention

LI Yuan-yuan, LAI Qing-you, SHANG De-ya, LIU Dong-xing   

  1. Department of Emergency, Provincial Hospital Affiliated to Shandong University, Jinan 250021, China
  • Received:2007-11-05 Revised:1900-01-01 Online:2008-05-16 Published:2008-05-16
  • Contact: LAI Qing-you

摘要: 目的分析冠状动脉介入(PCI)治疗急性ST段抬高型心肌梗死(SEMI)中应用替罗非班对冠状动脉内皮细胞功能的影响。方法PCI治疗的急性STEMI患者117例,分为实验组60例,术前给予替罗非班10μg/kg静脉3min内推注,随后以0.15μg/(kg·min)持续泵入36h;对照组57例,未给予替罗非班。手术结束前取冠状静脉窦血检测血管性血友病因子(vWF)水平、组织因子(TF)及内皮细胞凋亡数;围术期检测外周静脉血黏附分子sICAM-1和sVCAM-1含量;比较两组患者近期临床疗效。结果与对照组比较,实验组vWF、TF水平显著降低(P<0.05),内皮细胞凋亡数明显减少(P<0.05),sICAM-1、sVCAM-1浓度降低(P<0.05)。实验组术后住院期间难治性心绞痛、心肌再梗死及心力衰竭、30d心肌再梗死及心力衰竭发生率降低(P<0.05)。结论替罗非班在急性心肌梗死急诊PCI治疗中可保护冠脉内皮细胞功能,提高近期临床疗效。

关键词: 冠状动脉介入, 内皮细胞, 心肌梗死, 替罗非班

Abstract: To investigate the effects of Tirofiban on endothelial cell function in patients with st-segment elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention. MethodsOne hundred and seventeen patients with primary STEMI who underwent primary PCI were divided into two groups. Sixty patients in the experimental group were treated with Tirofiban, and fifty-seven patients in the control group were treated routinely without Tirofiban. Endothelial cell apoptosis, blood coagulation factor (TF and vWF), and concentration of the cellular adhesion molecules were determined, and the clinical outcomes in the near future were compared. Results Compared with the control group, concentration of the endothelial cell apoptosis, blood coagulation factor, and cellular adhesion molecules were lower in the experimental group (P<0.05). Incidences of re-infarction and heart failure in the hospital as well as after 30 days were much less in the experimental group compared with the control group(P<0.05). Conclusions Tirofiban could protect coronary artery endothelial function in patients with STEMI treated by percutaneous coronary intervention, and thereby improves the patient′s clinical outcome in the near future.

Key words: Tirofiban, Myocardial infarction, Percutaneous coronary intervention, Endothelial cell

中图分类号: 

  • R541.4
[1] 王晓磊 张海涛 张辉 郭成浩. 舒血宁注射液对高碘致培养血管内皮细胞损伤的保护作用[J]. 山东大学学报(医学版), 2209, 47(6): 38-.
[2] 徐宁宇 王磊 郝恩魁 苏国海. STEMI患者急诊PCI前口服阿托伐他汀对炎症介质及左心室功能的影响[J]. 山东大学学报(医学版), 2209, 47(6): 69-72.
[3] 谭琦,李娜,陶运明,唐浩,吴忠仕. 载血管内皮生长因子层层自组装提高异种去细胞血管生物相容性[J]. 山东大学学报(医学版), 2017, 55(5): 23-30.
[4] 高建步,杨守忠,李玉东,乔崇,张松雨. 南阳地区某医院急性心肌梗死患者院内用药10年变化趋势[J]. 山东大学学报(医学版), 2017, 55(5): 66-69.
[5] 李帅,王雅琳,孙忠文,朱梅佳. Nod样受体蛋白3炎性体在2型糖尿病脑微血管内皮细胞中的变化及变化机制[J]. 山东大学学报(医学版), 2017, 55(3): 6-11.
[6] 谈红,孟楠,晋群,苏莉,张夏晓,陈英剑,郝哲,刘晓红. 不同剂量培哚普利对兔急性心肌梗死后内皮祖细胞及心功能的影响[J]. 山东大学学报(医学版), 2017, 55(2): 55-60.
[7] 李晓宁,崔连群. 急性心肌梗死合并多支血管病变患者非梗死相关动脉处理的时机[J]. 山东大学学报(医学版), 2016, 54(8): 50-54.
[8] 胡浩然,袁梦,梁丽宁,季宪飞,李涛,陈永,刘福利,边红军,周轶,胡波,钟霞,商德亚. 心肌缺血后适应循环时间对急诊经皮冠状动脉介入治疗患者的影响[J]. 山东大学学报(医学版), 2016, 54(2): 57-62.
[9] 李冉冉,张鹏飞,袁冰,房菲菲, 韩明勇. 乳腺癌MCF-7细胞分泌的血管内皮生长因子诱导血管内皮细胞免疫功能抑制[J]. 山东大学学报(医学版), 2016, 54(2): 38-43.
[10] 李倩,戴桃李,韩炜,郭成浩. 血管内皮细胞活化在感染后肠易激综合征发病机制中的作用[J]. 山东大学学报(医学版), 2016, 54(12): 58-61.
[11] 曲立新,时兴华,杜怡峰. 急性缺血性脑卒中患者血浆PMP及EMP含量与预后的相关性[J]. 山东大学学报(医学版), 2016, 54(12): 32-36.
[12] 刘辉, 陈桐帅, 李娜, 王舒健, 李静媛, 卜培莉. Sirt3对人脐静脉内皮细胞衰老的影响[J]. 山东大学学报(医学版), 2015, 53(5): 41-45.
[13] 侯胜男, 崔连群. 侧支循环对急性心肌梗死患者近期预后的影响[J]. 山东大学学报(医学版), 2015, 53(12): 47-50.
[14] 付海燕, 胡占升, 杜红阳. 白藜芦醇衍生物TMS对脂多糖诱导血管内皮细胞表达NO、ICAM-1和NF-κB的影响[J]. 山东大学学报(医学版), 2015, 53(11): 10-15.
[15] 肖芳, 蒋卫东, 王晓红, 秦爱琼, 韩敏, 陈丽. 小鼠胰岛微血管内皮细胞外泌体的提取和鉴定方法[J]. 山东大学学报(医学版), 2015, 53(1): 6-9.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!